ISSN: 2155-6105

Journal of Addiction Research & Therapy

Drug Rehabilitation

Search results for
Drug Rehabilitation

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 4859

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Drug Rehabilitation

Drug rehabilitation is also called drug rehab or simply rehabs, is a way of medically or psychotherapeutic management of the addict person, for its dependency on such as alcohol, prescription drugs, like heroin, morphine, amphetamines (methylphenethylamine). The main purpose of drug rehabilitation is to ensure that the addict person start to cease substance abuse, in a way to dodge the psychological, legal, financial, social, and physical concerns; that can be triggered, especially by extreme abuse.

Related Journals of Drug Rehabilitation

Journal of Drug Metabolism & Toxicology, Journal of Bioanalysis & Biomedicine, Pharmaceutical Regulatory Affairs: , Journal of Alcoholism & Drug Dependence, Advanced Drug Delivery Reviews, Archives of Physical Medicine and Rehabilitation, Disability and Rehabilitation, Clinical Rehabilitation, American Journal of Physical Medicine and Rehabilitation, Journal of Rehabilitation Research and Development, Journal of Rehabilitation Medicine.

Drug Rehabilitation

Expert PPTs

Speaker PPTs

  • Sundeep Kumar Upadhyaya
    LONG TERM DRUG-FREE CLINICAL-REMISSION IN PATIENTS WITH RA ON cDMARDs
    | PDF Version
  • Tina Cloney
    Behavioral change strategies conducive to reducing rates of disease and disability and promoting rehabilitation and daily functioning
    | PDF Version
  • Li Yu-Jung
    Intra-maxillary Drug delivery and Bio-sensing via Dental Implant and its considerations
    | PDF Version
  • Carsten Worsoe
    The value of the “simulated study” as a tool to predict actual leachables in parenteral drug products
    | PDF Version
  • Diane Paskiet
    Qualifi cation of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations
    | PDF Version
  • Li-Chun Tsou
    Drug delivery device strategy for patient centric therapies
    | PDF Version
  • Neervalur V Raghavan
    Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges
    | PDF Version
  • Panayiotis P Constantinides
    Parenteral Drug Nanodispersions : Manufacturing, Characterization and In Vitro/In Vivo Performance Evaluation
    | PDF Version
  • Mohamed Elchalakani
    Mohamed Elchalakani-Dubai-Men’s-College-UAE-CFRP-Strengthening-and-Rehabilitation-of-Corroded-Steel-Pipelines-Under-Combined-Bending-and-Bearing
    | PDF Version
  • Jan Voskuil
    How antibodies can prevent medical progress and how they can be great tools?
    | PDF Version
  • Arshad mahmood
    TRANSPORT OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) ACROSS MUCUS AND CELLULAR INTERNALIZATION
    | PDF Version
  • Hugo Albrecht
    Towards pharmacological validation of MNKs as anti-cancer drug targets
    | PDF Version
  • Vivek Lal
    New drug development in type-2 diabetes mellitus : current and future trends – an overview
    | PDF Version
  • Joan Smith Sonneborn
    Novel anti-retroviral drug targets: Interfering siRNA and mitochondrial TERT expression
    | PDF Version
  • Barbara Klajnert-Maculewicz
    Sugar-modified PPI dendrimers as carriers of anti-leukemia drugs
    | PDF Version
  • Adel Nefzi
    “Adel Nefzi-Torrey-Pines-Institute-for-Molecular-Studies-USA-Diversity-Oriented-Synthesis-of-low-Molecular-Weight-Acyclic-and-Heterocyclic-Compounds-from-Resin-bound-Polyamides-Application-for-Drug-Discovery”
    | PDF Version
  • Wenru Wang
    Effects of home-based cardiac rehabilitation programme for patients with acute myocardial infarction: A randomized controlled trail
    | PDF Version
  • Cassandra Warner Frieson
    Fall Injury Prevention & Rehabilitation Services LLC
    | PDF Version
  • Tanvir Ahmed
    Sexual partners and condom use attitude: Qualitative findings among injecting drug users in Hai Phong, Vietnam
    | PDF Version
  • Mukesh Kumar
    Membrane fusion mediated cytosolic drug delivery through scFv targeted Sendai viral envelopes
    | PDF Version
  • Thomas J Franz
    Assessing the BA and BE of Topical Dermatologic Drug Products with Multiple Surrogate Methods
    | PDF Version
  • Rinat Islamov
    Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
    | PDF Version
  • Almas Okassov
    Chemical modification of anticancer Parasporins for decreasing of their toxicity
    | PDF Version
  • Akujobi Comfort
    Multi drug-resistant tuberculosis (MDR-TB) among HIV positive patients in a tertiary institution in south eastern Nigeria
    | PDF Version
  • Sevgi Gungor
    Micelles as nanosized carriers for skin delivery of drugs
    | PDF Version
  • Ru Band Lu
    Anti-Inflammation and neuroprotective drugs benefit the treatment of heroin dependent patients
    | PDF Version
  • Helmi Mardassi
    A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
    | PDF Version
  • Sungchul Ji
    Mathematical Models of RNA Expression Profiles: Potential Applications to Drug Discovery Research and Personalized Medicine
    | PDF Version
  • Anita Nair
    BCS-Based Biowaivers: Which Drugs are Eligible?
    | PDF Version
  • Adriana Katz
    Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
    | PDF Version
  • Eggehard Holler
    Biodegradable nanobrushes for drug delivery
    | PDF Version
  • Tao Lu
    Using VBIM technique to identify drug resistance genes in ovarian cancer
    | PDF Version
  • Navneet Sharma
    Transdermal patches based on solid lipid nanoparticles of Metformin: Novel approach for drug delivery of Type 2 diabetes
    | PDF Version
  • Viral Kansara
    Ocular melanin modulates pharmacokinetics and drug disposition of therapeutic agents
    | PDF Version
  • Richard A. Kenley
    Equilibrium binding interactions between lotrafilcon a soft contact lenses and the two prostaglandin anti-glaucoma drugs Bimatoprost and Tafluprost
    | PDF Version
  • Elena Gavrilova
    Application of drugs based on release-active antibodies as immunotherapy agents
    | PDF Version
  • William Lee
    Regulatory roadmap for initiating a cell therapy drug into clinical trials in the US
    | PDF Version
  • Krasimira Pekova
    Have FDA expedited programs really shortened drug review time? an analysis of newly approved therapies and how FDA expedited programs have impacted drug development timelines
    | PDF Version
  • Jasmin Kaur
    Helping clinicians connect: Understanding addiction from the perspective of a drug abuser
    | PDF Version
  • Matin Peters
    Cognitive-behavioral therapy as an effective treatment method in the ASEAN setting
    | PDF Version
  • Marcelo Febo
    3,4-Methylenedioxypyrovalerone (MDPV), a major bath salt drug, reduces functional connectivity in rat brain
    | PDF Version
  • Michel Tousignant
    Telerehabilitation for Total knee arthroplasty: Is there an issue related to virtual treatment without hands-on mobilisation for knee range of motion recovery?
    | PDF Version
  • Jim Klostergaard
    Magnetic vectoring for drug delivery to tumors: Past, present and is there a future?
    | PDF Version
  • Sree Harsha
    Optimization of particles size for lung specific drug delivery by way of microspheres
    | PDF Version
  • Mauro Comes Franchini
    Gold, silver magnesium and magnetic nanoparticles: Nanomedicine applications in drug delivery
    | PDF Version
  • W Wagner
    Tumor regression by means of magnetic drug targeting
    | PDF Version
  • Jung-Joon Min
    Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
    | PDF Version
  • Maria Paola COSTI
    A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
    | PDF Version
  • Vladimir Torchilin
    Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
    | PDF Version
  • Baharudin Ibrahim
    Personalizing drug treatment using pharmacometabonomic approach
    | PDF Version
  • Ruben Artero
    A Drosophila high-throughput drug screening platform identifies inhibitors of misregulated alternative splicing events in myotonic dystrophy
    | PDF Version
  • Vladimir E. Bondarenko
    Mathematical model of β1-adrenergic signaling in mouse ventricular myocytes as an in silico tool for the cardiovascular drug test
    | PDF Version
  • Maria ISAGULIANTS
    DNA vaccination against drug resistance in chronic viral infections, example of HIV-1
    | PDF Version
  • Grace London
    Development of aptamer based HIV-1 entry inhibitor prophylactic drugs
    | PDF Version
  • Aina Westrheim Ravna
    Novel sildenafil analogues: possible drugs for increased sensitivity to chemotherapeutic agents
    | PDF Version
High Impact List of Articles
Conference Proceedings